BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Casado M, Bosch J, García-pagán JC, Bru C, Bañares R, Bandi JC, Escorsell A, Rodríguez-láiz JM, Gilabert R, Feu F, Schorlemer C, Echenagusia A, Rodés J. Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings. Gastroenterology 1998;114:1296-303. [DOI: 10.1016/s0016-5085(98)70436-6] [Cited by in Crossref: 313] [Cited by in F6Publishing: 64] [Article Influence: 13.6] [Reference Citation Analysis]
Number Citing Articles
1 Praktiknjo M, Abu-Omar J, Chang J, Thomas D, Jansen C, Kupczyk P, Schepis F, Garcia-Pagan JC, Merli M, Meyer C, Strassburg CP, Pieper CC, Trebicka J. Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation. JHEP Rep 2021;3:100264. [PMID: 34013182 DOI: 10.1016/j.jhepr.2021.100264] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Intervent Radiol. 2014;31:235-242. [PMID: 25177083 DOI: 10.1055/s-0034-1382790] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 6.9] [Reference Citation Analysis]
3 Liu J, Ma J, Zhou C, Yang C, Huang S, Shi Q, Xiong B. Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation. Clin Transl Gastroenterol 2021;12:e00376. [PMID: 34140457 DOI: 10.14309/ctg.0000000000000376] [Reference Citation Analysis]
4 Miyazaki M, Yada M, Tanaka K, Senjyu T, Goya T, Motomura K, Kohjima M, Kato M, Masumoto A, Kotoh K. Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma. World J Gastroenterol 2017;23:5379-85. [PMID: 28839438 DOI: 10.3748/wjg.v23.i29.5379] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Dasarathy S, Mullen KD, Conjeevaram HS, Kaminsky-Russ K, Wills LA, McCullough AJ. Preservation of portal pressure improves growth and metabolic profile in the male portacaval-shunted rat. Dig Dis Sci 2002;47:1936-42. [PMID: 12353833 DOI: 10.1023/a:1019683703951] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
6 Khan S, Tudur Smith C, Williamson P, Sutton R. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev. 2006;CD000553. [PMID: 17054131 DOI: 10.1002/14651858.cd000553.pub2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
7 Aithal GP, Palaniyappan N, China L, Härmälä S, Macken L, Ryan JM, Wilkes EA, Moore K, Leithead JA, Hayes PC, O'Brien AJ, Verma S. Guidelines on the management of ascites in cirrhosis. Gut 2021;70:9-29. [PMID: 33067334 DOI: 10.1136/gutjnl-2020-321790] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
8 Bellis L, Moitinho E, Abraldes JG, Graupera M, García-Pagán JC, Rodés J, Bosch J. Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Transjugular intrahepatic portosystemic shunt. Gut 2003;52:130-3. [PMID: 12477774 DOI: 10.1136/gut.52.1.130] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
9 Khan S, Tudur Smith C, Williamson P, Sutton R. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev. 2006;CD000553. [PMID: 17054131 DOI: 10.1002/14651858.CD000553] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Martell M, Coll M, Ezkurdia N, Raurell I, Genescà J. Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol 2010;2:208-20. [PMID: 21160999 DOI: 10.4254/wjh.v2.i6.208] [Cited by in Crossref: 62] [Cited by in F6Publishing: 40] [Article Influence: 6.2] [Reference Citation Analysis]
11 Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51:1445-1449. [PMID: 20077563 DOI: 10.1002/hep.23478] [Cited by in Crossref: 319] [Cited by in F6Publishing: 264] [Article Influence: 29.0] [Reference Citation Analysis]
12 Nicolas C, Le Gouge A, d'Alteroche L, Ayoub J, Georgescu M, Vidal V, Castaing D, Cercueil JP, Chevallier P, Roumy J, Trillaud H, Boyer L, Le Pennec V, Perret C, Giraudeau B, Perarnau JM, Stic-Tips Group. Evaluation of Doppler-ultrasonography in the diagnosis of transjugular intrahepatic portosystemic shunt dysfunction: A prospective study. World J Hepatol 2017;9:1125-32. [PMID: 29026464 DOI: 10.4254/wjh.v9.i27.1125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Zhao D, Zhang G, Wang M, Zhang C, Li J. Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt. Clin Mol Hepatol 2019;25:210-7. [PMID: 30897897 DOI: 10.3350/cmh.2018.0083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Narahara Y, Kanazawa H, Fukuda T, Matsushita Y, Harimoto H, Kidokoro H, Katakura T, Atsukawa M, Taki Y, Kimura Y, Nakatsuka K, Sakamoto C. Transjugular intrahepatic portosystemic shunt vs paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. J Gastroenterol. 2011;46:78-85. [PMID: 20632194 DOI: 10.1007/s00535-010-0282-9] [Cited by in Crossref: 90] [Cited by in F6Publishing: 66] [Article Influence: 8.2] [Reference Citation Analysis]
15 Garcia-Tsao G. Transjugular intrahepatic portosystemic shunt in the management of refractory ascites. Semin Intervent Radiol 2005;22:278-86. [PMID: 21326706 DOI: 10.1055/s-2005-925554] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
16 Patidar KR, Sydnor M, Sanyal AJ. Transjugular intrahepatic portosystemic shunt. Clin Liver Dis 2014;18:853-76. [PMID: 25438287 DOI: 10.1016/j.cld.2014.07.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
17 Shukla A, Shreshtha A, Mukund A, Bihari C, Eapen CE, Han G, Deshmukh H, Cua IHY, Lesmana CRA, Al Meshtab M, Kage M, Chaiteeraki R, Treeprasertsuk S, Giri S, Punamiya S, Paradis V, Qi X, Sugawara Y, Abbas Z, Sarin SK. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2021;15:531-67. [PMID: 34240318 DOI: 10.1007/s12072-021-10189-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Matsushita Y, Narahara Y, Fujimori S, Kanazawa H, Itokawa N, Fukuda T, Takahashi Y, Kondo C, Kidokoro H, Atsukawa M. Effects of transjugular intrahepatic portosystemic shunt on changes in the small bowel mucosa of cirrhotic patients with portal hypertension. J Gastroenterol. 2013;48:633-639. [PMID: 22968470 DOI: 10.1007/s00535-012-0660-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
19 Kim HK, Kim YJ, Chung WJ, Kim SS, Shim JJ, Choi MS, Kim DY, Jun DW, Um SH, Park SJ, Woo HY, Jung YK, Baik SK, Kim MY, Park SY, Lee JM, Kim YS. Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data. Clin Mol Hepatol 2014;20:18-27. [PMID: 24757655 DOI: 10.3350/cmh.2014.20.1.18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
20 Levitt DG, Levitt MD. Quantitative modeling of the physiology of ascites in portal hypertension. BMC Gastroenterol 2012;12:26. [PMID: 22453061 DOI: 10.1186/1471-230X-12-26] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
21 Biecker E. Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol 2011;17:1237-48. [PMID: 21455322 DOI: 10.3748/wjg.v17.i10.1237] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
22 Wadhawan M, Dubey S, Sharma BC, Sarin SK, Sarin SK. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child’s status. Dig Dis Sci. 2006;51:2264-2269. [PMID: 17080245 DOI: 10.1007/s10620-006-9310-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
23 Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol 2017;9:603-12. [PMID: 28515846 DOI: 10.4254/wjh.v9.i12.603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 González-Abraldes J, García-Pagán JC, Bosch J. Nitric oxide and portal hypertension. Metab Brain Dis. 2002;17:311-324. [PMID: 12602508 DOI: 10.1023/a:1021957818240] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
25 Weitzman G, Schamberg NJ, Lake-Bakaar G. Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE. Dig Dis Sci. 2007;52:3270-3274. [PMID: 17638078 DOI: 10.1007/s10620-006-9371-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Haq I, Tripathi D. Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf)5:113-126. [PMID: 28533909 DOI: 10.1093/gastro/gox007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
27 Shimada T, Maruyama H, Kondo T, Sekimoto T, Takahashi M, Yokosuka O. Impact of splenic circulation: non-invasive microbubble-based assessment of portal hemodynamics. Eur Radiol 2015;25:812-20. [PMID: 25361826 DOI: 10.1007/s00330-014-3476-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
28 Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: evidence based treatment. World J Gastroenterol. 2014;20:5442-5460. [PMID: 24833875 DOI: 10.3748/wjg.v20.i18.5442] [Cited by in CrossRef: 87] [Cited by in F6Publishing: 63] [Article Influence: 14.5] [Reference Citation Analysis]
29 Saab S, Zhao M, Asokan I, Yum JJ, Lee EW. History of Hepatic Encephalopathy Is Not a Contraindication to Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites. Clin Transl Gastroenterol 2021;12:e00378. [PMID: 34333500 DOI: 10.14309/ctg.0000000000000378] [Reference Citation Analysis]
30 Nardelli S, Gioia S, Pasquale C, Pentassuglio I, Farcomeni A, Merli M, Salvatori FM, Nikolli L, Torrisi S, Greco F, Nicoletti V, Riggio O. Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt. Am J Gastroenterol. 2016;111:523-528. [PMID: 26925879 DOI: 10.1038/ajg.2016.29] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 5.6] [Reference Citation Analysis]
31 Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:573-82. [PMID: 19724251 DOI: 10.1038/nrgastro.2009.149] [Cited by in Crossref: 363] [Cited by in F6Publishing: 283] [Article Influence: 30.3] [Reference Citation Analysis]
32 Owen JM, Gaba RC. Transjugular Intrahepatic Portosystemic Shunt Dysfunction: Concordance of Clinical Findings, Doppler Ultrasound Examination, and Shunt Venography. J Clin Imaging Sci. 2016;6:29. [PMID: 27563495 DOI: 10.4103/2156-7514.186510] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
33 Ponziani FR, De Stefano V, Gasbarrini A. Viral cirrhosis: an overview of haemostatic alterations and clinical consequences. Mediterr J Hematol Infect Dis 2009;1:e2009033. [PMID: 21415961 DOI: 10.4084/MJHID.2009.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Feng AC, Liao CY, Fan HL, Chen TW, Hsieh CB. The modified Sugiura procedure as bridge surgery for liver transplantation: a case report. J Med Case Rep 2015;9:50. [PMID: 25888771 DOI: 10.1186/s13256-015-0522-y] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Punamiya SJ, Amarapurkar DN. Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease. Int J Hepatol 2011;2011:398291. [PMID: 21994854 DOI: 10.4061/2011/398291] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
36 Pedersen JS, Bendtsen F, Møller S. Management of cirrhotic ascites. Ther Adv Chronic Dis 2015;6:124-37. [PMID: 25954497 DOI: 10.1177/2040622315580069] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
37 Senousy BE, Draganov PV. Evaluation and management of patients with refractory ascites. World J Gastroenterol. 2009;15:67-80. [PMID: 19115470 DOI: 10.3748/wjg.15.67] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
38 García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep 2020;2:100122. [PMID: 32671331 DOI: 10.1016/j.jhepr.2020.100122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
39 Lee JY, Kim TY, Jeong WK, Kim Y, Kim J, Kim KW, Kim YH, Sohn JH. Clinically severe portal hypertension: role of multi-detector row CT features in diagnosis. Dig Dis Sci. 2014;59:2333-2343. [PMID: 24723070 DOI: 10.1007/s10620-014-3149-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
40 Qin JP, Jiang MD, Tang W, Wu XL, Yao X, Zeng WZ, Xu H, He QW, Gu M. Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center. World J Gastroenterol. 2013;19:8085-8092. [PMID: 24307804 DOI: 10.3748/wjg.v19.i44.8085] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
41 Bommana V, Shah P, Kometa M, Narwal R, Sharma P. A Case of Isolated Duodenal Varices Secondary to Chronic Pancreatitis with Review of Literature. Gastroenterology Research. 2010;3:281-286. [PMID: 27942309 DOI: 10.4021/gr249w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
42 Ketelsen D, Groezinger G, Maurer M, Lauer UM, Grosse U, Horger M, Nikolaou K, Syha R. Three-dimensional C-arm CT-guided transjugular intrahepatic portosystemic shunt placement: Feasibility, technical success and procedural time. Eur Radiol. 2016;26:4277-4283. [PMID: 27048535 DOI: 10.1007/s00330-016-4340-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Yamamoto J, Nagai M, Smith B, Tamaki S, Kubota T, Sasaki K, Ohmori T, Maeda K. Hand-assisted laparoscopic splenectomy and devascularization of the upper stomach in the management of gastric varices. World J Surg. 2006;30:1520-1525. [PMID: 16855808 DOI: 10.1007/s00268-005-0243-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
44 Moller S, Henriksen JH, Bendtsen F. Pathogenetic background for treatment of ascites and hepatorenal syndrome. Hepatol Int. 2008;2:416-428. [PMID: 19669317 DOI: 10.1007/s12072-008-9100-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
45 Nasr G, Hassan A, Ahmed S, Serwah A. Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites. J Cardiovasc Dis Res 2010;1:136-44. [PMID: 21187868 DOI: 10.4103/0975-3583.70914] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
46 Martinez-Palli G, Drake BB, Garcia-Pagan JC, Barbera JA, Arguedas MR, Rodriguez-Roisin R, Bosch J, Fallon MB. Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome. World J Gastroenterol. 2005;11:6858-6862. [PMID: 16425397 DOI: 10.3748/wjg.v11.i43.6858] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
47 Casadaban LC, Gaba RC. Percutaneous Portosystemic Shunts: TIPS and Beyond. Semin Intervent Radiol 2014;31:227-34. [PMID: 25177082 DOI: 10.1055/s-0034-1382789] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
48 Karagiannakis DS, Voulgaris T, Koureta E, Chloupi E, Papatheodoridis GV, Vlachogiannakos J. Role of Spleen Stiffness Measurement by 2D-Shear Wave Elastography in Ruling Out the Presence of High-Risk Varices in Cirrhotic Patients. Dig Dis Sci 2019;64:2653-60. [PMID: 30989464 DOI: 10.1007/s10620-019-05616-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
49 Chen SL, Xiao CJ, Wang S, Jin SY, Zhao JB. The Pull-Through Technique for Recanalization of Transjugular Intrahepatic Portosystemic Shunt Dysfunction. Gastroenterol Res Pract 2020;2020:9150173. [PMID: 32411208 DOI: 10.1155/2020/9150173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Nardelli S, Gioia S, Ridola L, Riggio O. Radiological Intervention for Shunt Related Encephalopathy. J Clin Exp Hepatol 2018;8:452-9. [PMID: 30564003 DOI: 10.1016/j.jceh.2018.04.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
51 Luigiano C, Iabichino G, Judica A, Virgilio C, Peta V, Abenavoli L. Role of endoscopy in management of gastrointestinal complications of portal hypertension. World J Gastrointest Endosc 2015;7:1-12. [PMID: 25610530 DOI: 10.4253/wjge.v7.i1.1] [Cited by in CrossRef: 4] [Article Influence: 0.7] [Reference Citation Analysis]
52 Sturm L, Bettinger D, Giesler M, Boettler T, Schmidt A, Buettner N, Thimme R, Schultheiss M. Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS). United European Gastroenterol J 2018;6:1380-90. [PMID: 30386611 DOI: 10.1177/2050640618795928] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
53 Al-Ghamdi H. Carvedilol in the treatment of portal hypertension. Saudi J Gastroenterol 2011;17:155-8. [PMID: 21372358 DOI: 10.4103/1319-3767.77251] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
54 Zhang Y, Wang Z, Yue ZD, Zhao HW, Wang L, Fan ZH, Wu YF, He FL, Liu FQ. Accurate ultrasonography-based portal pressure assessment in patients with hepatocellular carcinoma. World J Gastrointest Oncol 2020;12:931-41. [PMID: 32879669 DOI: 10.4251/wjgo.v12.i8.931] [Reference Citation Analysis]
55 Dasarathy S, Mullen KD, Conjeevaram HS, Kaminsky-Russ K, Wills LA, McCullough AJ. Preservation of portal pressure improves growth and metabolic profile in the male portacaval-shunted rat. Dig Dis Sci. 2002;47:1936-1942. [PMID: 12353833 DOI: 10.1023/a: 1019683703951] [Reference Citation Analysis]
56 Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan N, Mohanan M, Augustine P. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.World J Gastroenterol. 2020;26:5561-5596. [PMID: 33088154 DOI: 10.3748/wjg.v26.i37.5561] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
57 Parvinian A, Gaba RC. Outcomes of TIPS for Treatment of Gastroesophageal Variceal Hemorrhage. Semin Intervent Radiol. 2014;31:252-257. [PMID: 25177086 DOI: 10.1055/s-0034-1382793] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
58 Ricci P, Cantisani V, Lombardi V, Alfano G, D'Ambrosio U, Menichini G, Marotta E, Drudi FM. Is color-Doppler US a reliable method in the follow-up of transjugular intrahepatic portosystemic shunt (TIPS)? J Ultrasound. 2007;10:22-27. [PMID: 23396711 DOI: 10.1016/j.jus.2007.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
59 La Mura V, Nicolini A, Tosetti G, Primignani M. Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement. World J Hepatol. 2015;7:688-695. [PMID: 25866605 DOI: 10.4254/wjh.v7.i4.688] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
60 Pomier-Layrargues G, Bouchard L, Lafortune M, Bissonnette J, Guérette D, Perreault P. The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status. Int J Hepatol. 2012;2012:167868. [DOI: 10.1155/2012/167868] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
61 Teng D, Zuo H, Liu L, Dong J, Ding L. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment. Virol J. 2018;15:151. [PMID: 30285813 DOI: 10.1186/s12985-018-1067-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
62 Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55 Suppl 6:vi1-v12. [PMID: 16966752 DOI: 10.1136/gut.2006.099580] [Cited by in Crossref: 153] [Cited by in F6Publishing: 130] [Article Influence: 10.9] [Reference Citation Analysis]
63 Heinzow HS, Lenz P, Köhler M, Reinecke F, Ullerich H, Domschke W, Domagk D, Meister T. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis. World J Gastroenterol. 2012;18:5211-5218. [PMID: 23066315 DOI: 10.3748/wjg.v18.i37.5211] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
64 Fanelli F. The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips. ISRN Hepatol 2014;2014:762096. [PMID: 27335841 DOI: 10.1155/2014/762096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]